Blog: The Myriad gene patent case: its potential impact on the...
Aug 1, 2012 | Posted by: roboblogger | Full story: Mass High Tech
Recently, a federal appeals court heard oral arguments in a patent case, the ruling in which could significantly impact Massachusetts-based academic research organizations, biotechnology companies, and pharmaceutical companies.
|Senator Manchin: What My Daughter Did Should Be...||Jul 26||Philip Hinson||1|
|Merck's shingles vaccine, Zostavax, recommended... (Jun '08)||Jul 25||Blane||74|
|Gilead Sciences Under Investigation for Over-Ch...||Jul 21||Chris||1|
|U.S. drugmaker AbbVie finally wins Dublin's Shi...||Jul 21||fatbacks x||1|
|Exposure to smoke in cars may worsen asthma: study||Jul 16||Schmones||1|
|FDA Recalls Another Batch Of Generic Metoprolol||Jul 15||Doc||1|
|Generic Versions of Heart Drug Recalled for Ser...||Jul 15||Doc||1|